Results 181 to 190 of about 58,378 (265)

Risk stratification and anal cancer screening in immunocompetent women with genital HPV: Value of multicentric HSIL and performance of HPV‐based screening

International Journal of Cancer, Volume 159, Issue 4, Page 1017-1027, 15 August 2026.
What's new? Anal squamous cell carcinoma (ASCC) incidence is increasing, with most cases occurring in immunocompetent women. ASCC risk is linked in particular to genital human papillomavirus (HPV) infection and HPV‐associated high‐grade squamous intraepithelial lesions (HSILs).
Isabel Matas, Aureli Torné, Adela Saco, Cristina Martí, Ada Cardiel, Natalia Rakislova, Lorena Marimon, Ariel Glickman, Ingrid Victoria, Silvia Alós, Jesús Lopez‐Diaz, Pere Fusté, Jaume Ordi, Marta del Pino   +13 more
wiley   +1 more source

Understanding interobserver variability of pathologists to improve oral epithelial dysplasia grading. [PDF]

Oral Dis
Ng GTE, Phang SC, Yu KS, Tiwari L, Khurram SA, Sloan P, Kujan O.   +6 more
europepmc   +1 more source

Acute Food Bolus Impaction Secondary to a Fully Circumferential Inlet Patch

United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
Giorgi Kiladze, Wei On, Vivek Goodoory, Björn Rembacken, Peter Ellery   +4 more
wiley   +1 more source

Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma

Advanced Science, Volume 13, Issue 44, 7 August 2026.
This review explains how chronic liver injury progresses toward hepatocellular carcinoma through interconnected changes in gut microbes, metabolism, immunity, fibrosis, and diet. It highlights microbial metabolites, bile‐acid signaling, immune dysfunction, and nutritional or microbiome‐based interventions as opportunities to identify risk earlier ...
Yi Hu, Caiyan Lin, Lijie Zhang, Xue Jiang, Huawen Li, Yangzhe Wu   +5 more
wiley   +1 more source

Odontogenic Keratocyst With Moderate Epithelial Dysplasia: A Rare Entity. [PDF]

Cureus
Vivekbalamithran V, Ramalingam K, Ramani P, Neralla M, Jason AS.   +4 more
europepmc   +1 more source

Proteomic Differentiation of Colorectal Cancer From Normal Tissue via Ex Vivo E‐Biopsy: A Novel Approach to Molecular Sampling for Diagnostic Precision

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Colorectal cancer (CRC) is one of the most common malignancies worldwide. Early and accurate diagnosis remains a clinical priority, yet current biopsy techniques are invasive, spatially limited, and may not capture the molecular heterogeneity of tumors.
Gintautas Saulis, Edward Vitkin, Rita Saule, Julia Wise, Antanas Gulbinas, Žilvinas Dambrauskas, Sandra Ivanauskienė, Justas Žilinskas, Lina Poskiene, Alexander Golberg   +9 more
wiley   +1 more source

Advancing Non-Invasive Diagnosis of Oral Epithelial Dysplasia: Comparative Insights from In Vivo Optical Coherence Tomography and Histopathology. [PDF]

J Clin Med
Jerjes W, Hamdoon Z, Rashed D, Hopper C.
europepmc   +1 more source

High Expression of SSEA3 and Globo H Predicts Poor Outcomes in Resected Extrahepatic Cholangiocarcinoma: A Single‐Center Retrospective Cohort Study

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background SSEA3, SSEA4, and Globo H glycosphingolipids have been implicated in tumor progression and immune modulation across various malignancies. However, their clinical significance in extrahepatic cholangiocarcinoma (eCCA) remains largely undefined.
Tsai‐Hsien Hung, Jung‐Tung Hung, Chun‐Nan Yeh, Rodney Cheng‐En Hsieh, Sheng‐Chi Hsu, Alice L. Yu, Yenlin Huang   +6 more
wiley   +1 more source

Artificial intelligence based vision transformer application for grading histopathological images of oral epithelial dysplasia: a step towards AI-driven diagnosis. [PDF]

BMC Cancer
Hadilou M, Mahdavi N, Keykha E, Ghofrani A, Tahmasebi E, Arabfard M.   +5 more
europepmc   +1 more source

Therapeutic Efficacy of Metronomic Doxorubicin and Low Dose of Gamma Radiation on Breast Cancer Model

Cell Biochemistry and Function, Volume 44, Issue 8, August 2026.
ABSTRACT Breast cancer is the most common malignancy in females internationally. Doxorubicin (DOX) has been well‐thought‐out as the most effective regimen for breast cancer treatment for several years. The chronic side effects of DOX obligate us to control the dosage that can be used, although its efficacy.
Ibrahim Y. Abdelrahman, Mostafa Saif‐Elnasr, Zeinab R. Attia, Rania A. Abd El Azeem, Eman Khalifa, Mostafa A. Askar   +5 more
wiley   +1 more source